Pleurodesis in patients with malignant pleural effusions: Talc slurry or bleomycin? Results of a prospective randomized trial

World Journal of Surgery

Volumn 28, Issue 8, 2004, Pages 749-753

  Haddad, Fabio José ^a   Younes, Riad Naim ^a   Gross, Jefferson Luiz ^a   Deheinzelin, Daniel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE; STEROID; TALC; TALC SLURRY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURODESIS; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SAFETY; THORACOCENTESIS; THORAX RADIOGRAPHY; TREATMENT FAILURE;

ADULT; AGED; BLEOMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; POINT-OF-CARE SYSTEMS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RETREATMENT; SCLEROSING SOLUTIONS; TALC; TREATMENT FAILURE;

EID: 4744372072     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7269-8     Document Type: Article

References (19)

1. American Thoracic Society. Management of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 2000;162:1987-2001
2. Walker-Renard PB, Vaughan LM, Sahn AS. Chemical pleurodesis for malignant pleural effusions. Ann. Intern. Med. 1994;120:56-64
3. Masson T. Treatment of malignant pleural effusion with doxycycline. Scand. J. Infect. Dis. Suppl. 1988;53:29-34
4. Hartman DL, Gaither JM, Kesler KA, et al. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J. Thorac. Cardiovasc. Surg. 1993;105:743-748
5. Yim AP, Chan AT, Lee TW, et al. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusions. Ann. Thorac. Surg. 1996;62:1655-1658
6. Karnofsky DA. Problems and pitfalls in the evaluation of anticancer drugs. Cancer 1965;18:1517-1528
7. Ruckdeschel JC, Moores D, Lee JY, et al. Intrapleural therapy for malignant pleural effusions: a randomized comparison of bleomycin and tetracycline. Chest 1991;100:1528-1535
8. Hamed H, Fentiman IS, Chaudary MA, et al. Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br. J. Surg. 1989;76:1266-1267
9. De Campos JR, Vargas FS, Werebe E, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001;119:801-806
10. Webb WR, Ozmen V, Moulder PV, et al. Iodized talc pleurodesis for the treatment of pleural effusions. J. Thorac. Cardiovasc. Surg. 1992;103:881-886
11. Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest 1994;106:342-346
12. Ostrowski MJ. An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavitary bleomycin. Cancer 1986;57:721-727
13. Kessinger A, Wigtom RS. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusion: a randomized study. J. Surg. Oncol. 1987;36:81-83
14. Moores DWO. Malignant pleural effusion. Semin. Oncol. 1991;18:59-61
15. Zimmer PW, Hill M, Casey K, et al. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusion. Chest 1997;112:430-434
16. Rodriguez-Panadero R, Antony VB. Pleurodesis: state of the art. Eur. Respir. J. 1997;10:1648-1654
17. Sahn SA. Malignancy metastatic to the pleura. Clin. Chest Med. 1998;19:351-361
18. Belani CP, Einarson TR, Arikian SR, et al. Cost-effectiveness analysis of pleurodesis in the management of malignant pleural effusion. J. Oncol. Manag. 1995;4:24-34
19. Younes RN, Gross JL, Haddad FJ, et al. When to remove a chest tube? A randomized study with subsequent prospective consecutive validation. J. Am. Coll. Surg. 2002;195:658-662